Skip Ribbon Commands
Skip to main content

KANSHAS1 first-in-human study

Featured product:

9/6/2019 -  

In KANSHAS1 first-in-human study, 6-month outcome demonstrated: 
- Freedom from target limb amputation - 100%⁴ 
- Freedom from clinically driven target lesion revascularization(TLR) - 100%⁴ 
- Improvement in Rutherford classification – 93.3% of patients⁴

Please contact our sales representative for further information